IMR Press / CEOG / Special Issues / rare_ovarian_tumor

Rare Ovarian Tumors: New Insights into Diagnosis and Treatment

Submission deadline: 31 December 2023
Special Issue Editor
  • Yasuhiko Ebina, MD, PhD
    Department of Midwifery, Maternity Nursing and Women’s Health, Graduate School of Health Sciences and Faculty of Health Sciences, Hokkaido University, Sapporo, Japan
    Interests: ovarian tumors; pathology; cytology; surgery; women's mental health; perinatal care
Special Issue Information

Dear Colleagues,

Ovarian tumors consist of a wide diversity of histologic types, with non-epithelial ovarian tumors being the least frequent. As a result, large-scale clinical trials are challenging to conduct, and there is a need for evidence-based treatment strategies. We completed a retrospective study of 1,426 cases of granulosa cell carcinoma from the 75,241 ovarian tumors registered with the Japanese Society of Obstetrics and Gynecology (Ebina Y et al., Clinicopathological characteristics and prognostic factors of ovarian granulosa cell tumors: A JSGO-JSOG joint study. Gynecol Oncol. 2021 Nov;163(2):269–273.) However, so far there have been limited opportunities to analyze this data. This special issue will gather the latest clinical findings on the rare ovarian tumors mentioned below, thus providing insight into the gaps not covered by evidence-based treatment. The main histological types targeted include granulosa cell tumors and other sex cord-stromal tumors, as well as immature teratomas and other germ cell tumors. Additional rare ovarian tumors will also be considered for this program.

We also intend to share information about rare ovarian tumor types that present a unique picture in terms of treatment, diagnosis and clinical course. We hope this Special Issue will provide a forum for sharing knowledge about such tumors.

Prof. Dr. Yasuhiko Ebina
Guest Editor

Keywords
ovarian germ cell tumors
ovarian sex cord-stromal tumors
rare epithelial ovarian cancers
less common ovarian cancers
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Back to top